Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Immunovant, Inc. Common Stock (IMVT)

Biological Products, (no Disgnostic Substances)

https://www.immunovant.com

Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).

320 WEST 37TH STREET
NEW YORK, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/21/2019

Market Cap

4,398,313,713

Shares Outstanding

144,660,000

Weighted SO

144,661,930

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

ABUS --.--%

ARQT --.--%

LEGN --.--%

PTGX --.--%

ISEE --.--%

AKRO --.--%

MDGL --.--%

APLS --.--%

Beta

0.7130

Last Div

0.0000

Range

19.34-45.58

Chg

-0.8301

Avg Vol

1150090

Mkt Cap

4398313713

Exch

NASDAQ

Country

US

Phone

917 580 3099

DCF Diff

25.6803

DCF

4.5997

Div Yield

0.0000

P/S

2932.2091

EV Multiple

-13.3119

P/FV

8.0598

Div Yield %

0.0000

P/E

-16.1067

PEG

1.6201

Payout

0.0000

Current Ratio

13.0847

Quick Ratio

13.0847

Cash Ratio

12.4396

DSO

588.1367

DIO

0.0000

Op Cycle

588.1367

DPO

7309.9365

CCC

-6721.7998

Gross Margin

0.6327

Op Margin

-189.9293

Pretax Margin

-181.2627

Net Margin

-181.6993

Eff Tax Rate

-0.0024

ROA

-0.4622

ROE

-0.5207

ROCE

-0.5231

NI/EBT

1.0024

EBT/EBIT

0.9544

EBIT/Rev

-189.9293

Debt Ratio

0.0001

D/E

0.0001

LT Debt/Cap

0.0000

Total Debt/Cap

0.0001

Int Coverage

0.0000

CF/Debt

-3522.5507

Equity Multi

1.0827

Rec Turnover

0.6206

Pay Turnover

0.0499

Inv Turnover

0.0000

FA Turnover

2.3772

Asset Turnover

0.0025

OCF/Share

-1.6638

FCF/Share

-1.6672

Cash/Share

3.8334

OCF/Sales

-162.0373

FCF/OCF

1.0020

CF Coverage

-3522.5507

ST Coverage

-3522.5507

CapEx Coverage

-489.0463

Div&CapEx Cov

-489.0463

P/BV

8.0598

P/B

8.0598

P/S

2932.2091

P/E

-16.1067

P/FCF

-18.0590

P/OCF

-18.0611

P/CF

-18.0611

PEG

1.6201

P/S

2932.2091

EV Multiple

-13.3119

P/FV

8.0598

DPS

0.0000

Latest Headlines (EST)

The Motley Fool Jan 15, 06:30 5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond Benzinga Dec 21, 07:36 Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday GlobeNewswire Inc. Dec 20, 16:30 Immunovant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease Benzinga Dec 01, 15:00 Analyst Ratings for Immunovant Benzinga Nov 15, 12:00 Where Immunovant Stands With Analysts

Revenue Product Segmentation